StockData
Karyopharm Therapeutics Inc. logo

Karyopharm Therapeutics Inc. (KPTI) bonds

KPTINasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPTIQ
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30
$0.04−0.01 (-20.00%)

Close on Nov 9, 2026Market cap $1.16KP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Karyopharm Therapeutics reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2021

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Karyopharm Therapeutics's 10-Q for the period ended Jun 30, 2026

IssueMaturesAmount issuedCarrying value
Amended Term LoanMay 31, 2028$128.98M$153.64M
Two Thousand Twenty Eight Notes
Convertible at $7 a share
Oct 15, 2028$15.65M$19.24M
New Two Thousand Twenty Nine NotesMay 13, 2029$107.97M$138.27M
New Two Thousand Twenty Nine Notes And Two Thousand Twenty Nine Notes–$105.60M$89.97M
Six Percentage Secured Convertible Senior Notes Due Two Thousand Twenty Nine
Convertible
–$111.00M–
Two Thousand Twenty Nine Notes–$0–

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySize
Credit Agreement And Term Loan$100.00M

See a number that looks wrong?